TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/17/2026
Back to search
Official data from USPTO
PAIGE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
57
Latest update
06/19/2026
Trademark type
Word
Nice classes
42, 44
Filing date
02/20/2019
Registration date
11/24/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2026
Last transaction
06/19/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/21/2019
First use in commerce
02/21/2019
Drawing code
4
Owner type
03
Owner location
New York, NY, US
Examiner
MORRIS, KRISTINA KLOIBER
Current location
Historical data usage
Holders and representatives
Holders
PAIGE.AI, Inc.
Representatives
Mark Leonardo NUTTER, MCCLENNEN & FISH, LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Software as a service (SaaS) services featuring software for artificial intelligencemachine learningdeep learningstatistical learningdata miningcontextual prediction; software as a service (SaaS) services featuring software for use in disease pathologysoftware that reads digital slides and provides diagnoses; software as a service (SaaS) services featuring software for use in diagnosis of diseasesstatesconditions; software as a service (SaaS) services featuring software for use in evaluation of prognosis relating to diseasesstatesconditions; software as a service (SaaS) services featuring software for use in monitoring of diseasesstatesconditions; software as a service (SaaS) services featuring software for use to detect or identify predispositions to diseasesstatesconditions; software as a service (SaaS) services featuring software to detect the recurrence of diseasesstatesconditions; software as a service (SaaS) services featuring software to detectmonitorevaluate patients' responses to treatment of diseasesstatesconditions; software as a service (SaaS) services featuring software for use in clinical management of diseasesstatesconditions; software as a service (SaaS) services featuring software for use in the selection of treatment of diseasesstatesconditions; software as a service (SaaS) services featuring software for use in prevention of diseasesstatesconditions; software as a service (SaaS) services featuring software for use in palliation or treatment of diseasesstatesconditions; software as a service (SaaS) services featuring software for use in research or development in the field of life sciences; software as a service (SaaS) services featuring software for use in research or development in the field of medicine; software as a service (SaaS) services featuring software for use in research or development in the field of healthcare; software as a service (SaaS) services featuring software for use in research or development in the field of cancer; software as a service (SaaS) services featuring software for use in research or development in the field of oncology; software as a service (SaaS) services featuring software for use in research or development in the field of pathology; design and development of AI-powered computer software that analyzes clinical pathology slides and diagnoses diseases; medical research; scientific research and development services in the field of pathology; research and development services in the field of medicine; research and development services in the field of cancer; research and development services in the field of healthcare; research and development services in the field of life sciences; research and development services in the field of oncology; medical and scientific research services in the field of pathology; medical and scientific research services in the field of cancer; medical and scientific research services in the field of healthcare; medical and scientific research services in the field of life sciences; medical and scientific research services in the field of oncology; research and development of technology in the field of pathology; research and development of technology in the field of medicine; research and development of technology in the field of cancer; research and development of technology in the field of healthcare; research and development of technology in the field of life sciences; research and development of technology in the field of oncology; providing medical research and scientific research information via the internet; electronic scanning of clinical pathology slides; software as a service services (SaaS) featuring software for use in the analysis of clinical pathology slides; medical and scientific testing services for research purposes
Class 44
Medical services; cancer therapy services; medical testingthe review and analysis of patients' clinical slides to identify additional recommended medical testing; medical testing for the diagnosis of diseasesstatesconditions; medical testing for evaluation of prognosis relating to diseasesstatesconditions; medical testing for the monitoring of diseasesstatesconditions; medical testing to detect or identify predispositions to diseasesstatesconditions; medical testing to detect or determine the recurrence of diseasesstatesconditions; medical testing to detectmonitorevaluate responses to treatment of diseasesstatesconditions; medical testing to evaluate clinical management of diseasesstatesconditions; medical testing for selection of treatment for diseasesstatesconditions; medical testing to evaluate or facilitate prevention of diseasesstatesconditions; medical testing to selectfacilitatemonitorevaluate palliation or treatment of diseasesstates or conditions; medical testing in the field of cancer; medical testing in the field of oncology; medical diagnostic testingmonitoringreporting services; medical analysis or advisory services in the field of cancer; medical analysis or advisory services in the field of oncology; medical analysis or advisory services for medical treatment; medical analysis or advisory services for the diagnosis of diseasesstatesconditions; medical analysis or advisory services for the evaluation of prognosis relating to diseasesstatesconditions; medical analysis or advisory services relating to monitoring diseasesstatesconditions; medical analysis or advisory services relating to the detection or identification of predispositions to diseasesstatesconditions; medical analysis or advisory services relating to the detection or determination of the recurrence of diseasesstatesconditions; medical analysis or advisory services relating to the detectionmonitoringevaluation of responses to treatment of diseasesstatesconditions; medical analysis or advisory services relating to the clinical management of diseasesstatesconditions; medical analysis or advisory services relating to the selection of treatment for diseasesstatesconditions; medical analysis or advisory services relating to the prevention of diseasesstatesconditions; medical analysis or advisory services relating to the palliation or treatment of diseasesstates or conditions; qualitative image analysis in the field of digital pathology for medical purposes; quantitative image analysis in the field of digital pathology for medical purposes; providing non-research related medical information via the internet; medical analysis services for the diagnosis of cancer by reviewing pathological samples on slides
Publications
History of USPTO decisions and trademark events.
57 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/17/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/17/2026
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/04/2026
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/04/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/04/2026
E815
TEAS SECTION 8 & 15 RECEIVED
12/01/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/24/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/29/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/29/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/29/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/29/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/29/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/24/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/22/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/21/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/21/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/21/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/13/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/13/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/13/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/13/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/13/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/13/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/11/2020
GNRT
NON-FINAL ACTION E-MAILED
09/11/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
09/11/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/13/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/12/2020
IUAF
USE AMENDMENT FILED
07/31/2020
EISU
TEAS STATEMENT OF USE RECEIVED
07/31/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/08/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/08/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/08/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/24/2020
EX1G
SOU EXTENSION 1 GRANTED
04/22/2020
EXT1
SOU EXTENSION 1 FILED
04/22/2020
EEXT
SOU TEAS EXTENSION RECEIVED
04/22/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/22/2019
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
09/11/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/14/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/14/2019
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/31/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2019
PUBO
PUBLISHED FOR OPPOSITION
07/02/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/12/2019
ALIE
ASSIGNED TO LIE
05/29/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/15/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
05/15/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/15/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
05/15/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/15/2019
DOCK
ASSIGNED TO EXAMINER
05/01/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2019
NWAP
NEW APPLICATION ENTERED
02/23/2019
Continuous trademark protection
Get notified about every new filing that threatens PAIGE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.